1383-P: Longitudinal Changes in Transition Readiness (TR) in Teens with Type 1 Diabetes (T1D) Are Unrelated to Glycemic Control

Autor:	Eveline R. Goethals, Lisa K. Volkening, Deborah A. Butler, Dayna E. Mcgill, Persis V. Commissariat, Lori M. Laffel
Rok vydání:	2019
Předmět:	medicine.medical_specialty Type 1 diabetes Transition readiness Treatment adherence business.industry Endocrinology Diabetes and Metabolism education Parent reports Adult care medicine.disease Diabetes mellitus Internal Medicine medicine Psychiatry business human activities Glycemic
Zdroj:	Diabetes. 68
ISSN:	1939-327X 0012-1797
DOI:	10.2337/db19-1383-p
Popis:	Aim: During adolescence, teens with T1D increase self-care, anticipating future independence. To assess TR skills (i.e., affective, behavioral, and cognitive preparation to transfer from pediatric to adult care), teens with T1D and parents completed the validated Readiness for Independent Self-Care Questionnaire (RIS-Q). Methods: Teens, ages 13-17, with T1D and parents completed RIS-Q every 6 months over 18 months. Teen and parent reports of teen treatment adherence and self-efficacy were assessed as predictors of TR and A1c with longitudinal mixed models. Results: At entry, teens (N=178, 52% male, 88% white) had mean±SD age 14.9±1.3 years, T1D duration 7.4±3.7 years, 4.9±2.0 BG checks/day, and A1c 8.5±1.0%; 67% were pump users. Teen and parent reported TR increased over time while teen A1c was unchanged (Figure). In multivariate models, teen age, teen reported adherence, and self-efficacy predicted TR (all p Conclusion: Teen TR increased with age and over time but was unrelated to A1c, suggesting a disconnect between teen perceptions of self-care readiness and self-care behaviors. While TR may be important, it is insufficient, highlighting need to improve self-care behaviors and A1c in teens with T1D. Disclosure E.R. Goethals: None. L.K. Volkening: None. P.V. Commissariat: None. D.A. Butler: None. D.E. McGill: None. L.M. Laffel: Advisory Panel; Self; Lilly Diabetes, Novo Nordisk A/S, Roche Diabetes Care, Sanofi. Consultant; Self; AstraZeneca, Boehringer Ingelheim International GmbH, Dexcom, Inc., Janssen Pharmaceuticals, Inc., UpToDate. Funding National Institutes of Health (R01DK095273, P30DK036836, T32DK007260, K12DK094721); JDRF (2-SRA-2014-253-M-B)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::94f94556ed16836471c21678671cffd4 https://doi.org/10.2337/db19-1383-p Zobrazit plný text záznamu